Sequence variation of human papillomavirus Type 31 long control region: Phylogenetic and functional implications

Journal of Medical Virology

Volumn 85, Issue 5, 2013, Pages 852-859

  Ferenczi, Annamária ^a   Gyöngyösi, Eszter ^a   Szalmás, Anita ^a   Hernádi, Zoltán ^a   Tóth, Zoltán ^a   Kónya, József ^a   Veress, György ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

HPV 31; LCR; Sequence heterogeneity; Transcriptional activity

Indexed keywords

LUCIFERASE;

ADULT; ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 31; HUNGARY; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; UTERINE CERVIX CANCER; VIRUS GENOME; VIRUS ONCOGENE;

ADULT; CERVIX UTERI; CLUSTER ANALYSIS; DNA, VIRAL; FEMALE; GENE EXPRESSION PROFILING; GENETIC VARIATION; HUMAN PAPILLOMAVIRUS 31; HUMANS; HUNGARY; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; REGULATORY SEQUENCES, NUCLEIC ACID; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPES;

EID: 84875683080     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23542     Document Type: Article

References (32)

1. Bernard HU, Calleja-Macias IE, Dunn ST. 2006. Genome variation of human papillomavirus types: Phylogenetic and medical implications. Int J Cancer 118:1071-1076.
2. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, de Villiers EM. 2010. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401:70-79.
3. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. 2002. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244-265.
4. Calleja-Macias IE, Kalantari M, Huh J, Ortiz-Lopez R, Rojas-Martinez A, Gonzalez-Guerrero JF, Williamson AL, Hagmar B, Wiley DJ, Villarreal L, Bernard HU, Barrera-Saldana HA. 2004. Genomic diversity of human papillomavirus-16, 18, 31 and 35 isolates in a Mexican population and relationship to European, African, and Native American variants. Virology 319:315-323.
5. Calleja-Macias IE, Villa LL, Prado JC, Kalantari M, Allan B, Williamson AL, Chung LP, Collins RJ, Zuna RE, Dunn ST, Chu TY, Cubie HA, Cuschieri K, von Knebel-Doeberitz M, Martins CR, Sanchez GI, Bosch FX, Munoz N, Bernard HU. 2005. Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35 52, and 58, four close relatives of human papillomavirus type 16. J Virol 79:13630-13640.
6. Cento V, Rahmatalla N, Ciccozzi M, Perno CF, Ciotti M. 2011. Intratype variations of HPV 31 and 58 in Italian women with abnormal cervical cytology. J Med Virol 83:1752-1761.
7. Chen Z, Schiffman M, Herrero R, Desalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD. 2011. Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS ONE 6:e20183.
8. Cornut G, Gagnon S, Hankins C, Money D, Pourreaux K, Franco EL, Coutlee F. 2010. Polymorphism of the capsid L1 gene of human papillomavirus types 31, 33 and 35. J Med Virol 82:1168-1178.
9. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. 2004. Classification of papillomaviruses. Virology 324:17-27.
10. Gagnon S, Hankins C, Tremblay C, Pourreaux K, Forest P, Rouah F, Coutlee F. 2005. Polymorphism of human papillomavirus type 31 isolates infecting the genital tract of HIV-seropositive and HIV-seronegative women at risk for HIV infection. J Med Virol 75:213-221.
11. Ho L, Chan SY, Burk RD, Das BC, Fujinaga K, Icenogle JP, Kahn T, Kiviat N, Lancaster W, Mavromara-Nazos P, Labropoulou V, Mitrani-Rosenbaum S, Norrild B, Pillai MR, Stoerker J, Syrjaenen K, Syrjaenen S, Tay SK, Villa LL, Wheeler CM, Williamson AL, Bernard HU. 1993. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol 67:6413-6423.
12. Kammer C, Warthorst U, Torrez-Martinez N, Wheeler CM, Pfister H. 2000. Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity. J Gen Virol 81:1975-1981.
13. Kanaya T, Kyo S, Laimins LA. 1997. The 5′ region of the human papillomavirus type 31 upstream regulatory region acts as an enhancer which augments viral early expression through the action of YY1. Virology 237:159-169.
14. Konya J, Veress G, Juhasz A, Szarka K, Sapy T, Hernadi Z, Gergely L. 2000. Additional human papillomavirus types detected by the hybrid capture tube test among samples from women with cytological and colposcopical atypia. J Clin Microbiol 38:408-411.
15. Kyo S, Tam A, Laimins LA. 1995. Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors. Virology 211:184-197.
16. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. 2011. Human papillomavirus type distribution in 30, 848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer 128:927-935.
17. Lopez-Saavedra A, Gonzalez-Maya L, Ponce-de-Leon S, Garcia-Carranca A, Mohar A, Lizano M. 2009. Functional implication of sequence variation in the long control region and E2 gene among human papillomavirus type 18 variants. Arch Virol 154:747-754.
18. Lorincz AT, Lancaster WD, Temple GF. 1986. Cloning and characterization of the DNA of a new human papillomavirus from a woman with dysplasia of the uterine cervix. J Virol 58:225-229.
19. Mantovani F, Banks L. 2001. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20:7874-7887.
20. Munger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M, Zacny VL. 2001. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20:7888-7898.
21. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527.
22. O'Connor MJ, Stunkel W, Koh CH, Zimmermann H, Bernard HU. 2000. The differentiation-specific factor CDP/Cut represses transcription and replication of human papillomaviruses through a conserved silencing element. J Virol 74:401-410.
23. Raiol T, Wyant PS, de Amorim RM, Cerqueira DM, Milanezi NG, Brigido Mde M, Sichero L, Martins CR. 2009. Genetic variability and phylogeny of the high-risk HPV-31, -33, -35, -52, and -58 in central Brazil. J Med Virol 81:685-692.
24. Sailaja G, Watts RM, Bernard HU. 1999. Many different papillomaviruses have low transcriptional activity in spite of strong epithelial specific enhancers. J Gen Virol 80:1715-1724.
25. Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A, Desalle R, Befano B, Yu K, Safaeian M, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, Solomon D, Castle PE, Burk RD. 2010. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res 70:3159-3169.
26. Sen E, Bromberg-White JL, Meyers C. 2002. Genetic analysis of cis regulatory elements within the 5′ region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle. J Virol 76:4798-4809.
27. Sichero L, Franco EL, Villa LL. 2005. Different P105 promoter activities among natural variants of human papillomavirus type 18. J Infect Dis 191:739-742.
28. Sichero L, Ferreira S, Trottier H, Duarte-Franco E, Ferenczy A, Franco EL, Villa LL. 2007. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer 120:1763-1768.
29. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28:2731-2739.
30. Veress G, Szarka K, Dong XP, Gergely L, Pfister H. 1999. Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16. J Gen Virol 80:1035-1043.
31. Veress G, Murvai M, Szarka K, Juhász A, Kónya J, Gergely L. 2001. Transcriptional activity of human papillomavirus type 16 variants having deletions in the long control region. Eur J Cancer 37:1946-1952.
32. Xi LF, Schiffman M, Koutsky LA, Hulbert A, Lee SK, Defilippis V, Shen Z, Kiviat NB. 2012. Association of human papillomavirus type 31 variants with risk of cervical intraepithelial neoplasia grades 2-3. Int J Cancer 131:2300-2307.